{"filing":{"accession_number":"0001683168-26-005338","cik":"0000882291","ticker":"AEMD","company_name":"AETHLON MEDICAL INC","form":"8-K","filing_date":"2026-07-07","report_date":null,"primary_document":"aethlon_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316826005338/aethlon_8k.htm"},"events":[{"id":16554,"run_id":14788,"accession_number":"0001683168-26-005338","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Aethlon Medical entered into a Securities Purchase Agreement on July 6, 2026, to sell 263,000 shares of common stock, 5,633,009 common warrants, 5,370,009 pre-funded warrants, and 225,320 placement agent warrants in a registered public offering priced at $0.71 per unit, raising approximately $4.0 million in gross proceeds. This dilutive equity issuance materially increases the share count and warrant overhang, affecting existing shareholders' ownership percentages and future earnings per share.","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-07-07","form":"8-K","submitted_at":null,"items":[{"id":14692,"accession_number":"0001683168-26-005338","item_number":"1.01","item_title":"Entry into a Material","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Aethlon Medical entered into a Securities Purchase Agreement on July 6, 2026, to sell 263,000 shares of common stock, 5,633,009 common warrants, 5,370,009 pre-funded warrants, and 225,320 placement agent warrants in a registered public offering priced at $0.71 per unit, raising approximately $4.0 million in gross proceeds. This is a material dilutive equity issuance that increases the share count and warrant overhang substantially, affecting existing shareholders' ownership percentages and future earnings per share.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T10:03:51.283151+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14693,"accession_number":"0001683168-26-005338","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Aethlon Medical announced the pricing of a follow-on offering of 5,633,009 shares of common stock (or pre-funded warrants) and accompanying warrants at $0.7101 per share, generating approximately $4.0 million in gross proceeds. This is a dilutive equity issuance under a registered Form S-1, priced at-the-market under NASDAQ rules, which materially affects existing shareholders through dilution and is a significant capital-raising event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T10:03:51.283151+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14692,"accession_number":"0001683168-26-005338","item_number":"1.01","item_title":"Entry into a Material","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Aethlon Medical entered into a Securities Purchase Agreement on July 6, 2026, to sell 263,000 shares of common stock, 5,633,009 common warrants, 5,370,009 pre-funded warrants, and 225,320 placement agent warrants in a registered public offering priced at $0.71 per unit, raising approximately $4.0 million in gross proceeds. This is a material dilutive equity issuance that increases the share count and warrant overhang substantially, affecting existing shareholders' ownership percentages and future earnings per share.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T10:03:51.283151+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-07-07"},{"id":14693,"accession_number":"0001683168-26-005338","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Aethlon Medical announced the pricing of a follow-on offering of 5,633,009 shares of common stock (or pre-funded warrants) and accompanying warrants at $0.7101 per share, generating approximately $4.0 million in gross proceeds. This is a dilutive equity issuance under a registered Form S-1, priced at-the-market under NASDAQ rules, which materially affects existing shareholders through dilution and is a significant capital-raising event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T10:03:51.283151+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-07-07"}]}